Insulin Nation

NOVEMBER 27, 2018

In his studies, Type 1 diabetic patients have significantly benefited when their daily insulin regimen is supplemented with drugs developed to treat Type 2 diabetes. In 2011 he published a paper on liraglutide , marketed by Novo Nordisk under the brand names Victoza. Research & studies.

Drug Development 70

Drug Development 70

Insulin Nation

JUNE 4, 2019

SGLT2 Development and Method of Action. Ever since the first SGLT2 inhibitor (dapagliflozin) was approved by the EU in 2011 and the USA in 2014, it and another nine gliflozin drugs developed since then have been considered for (off-label) use in Type-1 diabetes, as well as in Type-2 diabetes for which they were first approved.

Drug Development 52

Drug Development 52

Insulin Nation

NOVEMBER 14, 2016

Could this mean that there will be a streamlined pipeline for diabetes drug development? According to a 2011 law review of presidential authority, presidents can propose streamlined regulations, but agencies still must go through a public process to establish the harm vs. benefit of changed regulations. It’s unclear.

Drug Development 75

Drug Development Pharmaceuticals 75